TuHURA Biosciences HURA
NASDAQ HURA
$1.91 -0.07 (-3.76%)
As of: Oct 2, 2026 · 11:58 AM EDT

TuHURA Biosciences (HURA) Capital Expenditures (2022 - 2026)

Updated

TuHURA Biosciences' Capital Expenditures was $136,978 in Q2 2026, compared with $5,561 a year earlier and up 180.4% from the prior quarter.

Analysis

TuHURA Biosciences (HURA) Capital Expenditures (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, TuHURA Biosciences' Capital Expenditures was $213,674 through Jun 30, 2026, up 104.0% year-over-year; for FY2025, it was $76,083, up 31.4% from FY2024.

  • Capital Expenditures shows a four-year compound annual growth rate of 75.6% (FY2021 to FY2025).
  • In earlier years, Capital Expenditures was $57,906 in FY2024 (-26.9%), $79,224 in FY2023 and $8,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 TuHURA Biosciences 39.19 Mn 39.19 Mn - 136,978.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136,978.00
Mar 31, 2026 48,846.00
Dec 31, 2025 27,850.00
Jun 30, 2025 5,561.00
Mar 31, 2025 42,672.00
Dec 31, 2023 -152,776.00
Sep 30, 2022 232,000.00
API Access

TuHURA Biosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HURA&period=max&api_key=YOUR_API_KEY